What is the share price of Max Healthcare Institute Ltd (MAXHEALTH) today?
The share price of MAXHEALTH as on 7th November 2025 is ₹1130.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Max Healthcare Institute Ltd (MAXHEALTH) share?
The past returns of Max Healthcare Institute Ltd (MAXHEALTH) share are- Past 1 week: -4.01%
- Past 1 month: 3.48%
- Past 3 months: -11.46%
- Past 6 months: -2.65%
- Past 1 year: 4.21%
- Past 3 years: 143.15%
- Past 5 years: 882.88%
What are the peers or stocks similar to Max Healthcare Institute Ltd (MAXHEALTH)?
The peers or stocks similar to Max Healthcare Institute Ltd (MAXHEALTH) include:What is the dividend yield % of Max Healthcare Institute Ltd (MAXHEALTH) share?
The current dividend yield of Max Healthcare Institute Ltd (MAXHEALTH) is 0.13.What is the market cap of Max Healthcare Institute Ltd (MAXHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Max Healthcare Institute Ltd (MAXHEALTH) is ₹109415.49 Cr as of 7th November 2025.What is the 52 week high and low of Max Healthcare Institute Ltd (MAXHEALTH) share?
The 52-week high of Max Healthcare Institute Ltd (MAXHEALTH) is ₹1314.30 and the 52-week low is ₹936.25.What is the PE and PB ratio of Max Healthcare Institute Ltd (MAXHEALTH) stock?
The P/E (price-to-earnings) ratio of Max Healthcare Institute Ltd (MAXHEALTH) is 101.70. The P/B (price-to-book) ratio is 11.66.Which sector does Max Healthcare Institute Ltd (MAXHEALTH) belong to?
Max Healthcare Institute Ltd (MAXHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Max Healthcare Institute Ltd (MAXHEALTH) shares?
You can directly buy Max Healthcare Institute Ltd (MAXHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Max Healthcare Institute Ltd
MAXHEALTH Share Price
1,130.500.45% (+5.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MAXHEALTH Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MAXHEALTH Performance & Key Metrics
MAXHEALTH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 95.34 | 11.66 | 0.13% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.84 | 5.81 | 0.59% |
79%
Analysts have suggested that investors can buy this stock
from 19 analysts
Price Upside
Earnings Growth
Rev. Growth
MAXHEALTH Company Profile
Max Healthcare is provider of home health care services including Patient Care, Healthcare Services, and Hospitals.
APOLLOHOSP
PE Ratio
77.39
77.39
1Y Return
11.68%
11.68%
Buy Reco %
89.66
89.66
FORTIS
PE Ratio
98.48
98.48
1Y Return
62.45%
62.45%
Buy Reco %
93.33
93.33
PE Ratio
46.78
46.78
1Y Return
45.64%
45.64%
Buy Reco %
75.00
75.00
ASTERDM
PE Ratio
6.61
6.61
1Y Return
55.43%
55.43%
Buy Reco %
100.00
100.00
MEDANTA
PE Ratio
71.46
71.46
1Y Return
19.23%
19.23%
Buy Reco %
71.43
71.43
MAXHEALTH Sentiment Analysis
MAXHEALTH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MAXHEALTH Stock Summary · August 2025
The company demonstrated robust financial performance with a 27% year-on-year revenue growth and a 23% increase in operating EBITDA, despite facing challenges from rising operational costs and the integration of new facilities. Strategic expansion efforts include adding significant bed capacity and enhancing oncology services, which are expected to drive future revenue growth, particularly in underserved regions. However, the integration of newly acquired hospitals has initially diluted average revenue per occupied bed, necessitating a focus on optimizing occupancy and service quality. While net debt is projected to rise due to ongoing expansions, management remains optimistic about maintaining a manageable debt-to-EBITDA ratio and improving overall profitability as new facilities mature. Community engagement initiatives further underscore the company's commitment to social responsibility amidst its growth trajectory.
MAXHEALTH Stock Growth Drivers
MAXHEALTH Stock Growth Drivers
8Strong Financial Performance
The company reported a robust financial performance in Q1 FY26, achieving a 27% year-on-year growth
Expansion Initiatives
The company is actively expanding its capacity by adding approximately 1,000 brownfield and 500 greenfield
MAXHEALTH Stock Challenges
MAXHEALTH Stock Challenges
4Occupancy Rate Challenges
The overall occupancy rate for base level hospitals is approximately 79.9%, with expectations to reach
Subdued Performance of Acquired Hospitals
The financial performance of the recently acquired hospitals shows mixed results. While Lucknow has experienced
MAXHEALTH Forecast
MAXHEALTH Forecasts
Price
Revenue
Earnings
MAXHEALTH Share Price Forecast
MAXHEALTH Share Price Forecast
2025
Current
₹1,125.40
Baseline
Forecast for Nov 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,125.40
Baseline
Forecast for Nov 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MAXHEALTH Company Revenue Forecast
MAXHEALTH Company Revenue Forecast
2025
Current
₹7.18
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹7.18
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MAXHEALTH Stock EPS (Earnings Per Share) Forecast
MAXHEALTH Stock EPS (Earnings Per Share) Forecast
2025
Current
₹11.07
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹11.07
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MAXHEALTH
MAXHEALTH
Income
Balance Sheet
Cash Flow
Annual Normal View
MAXHEALTH Income Statement
MAXHEALTH Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,667.82 | 1,794.47 | 1,748.07 | 1,107.11 | 2,619.41 | 4,058.82 | 4,970.61 | 5,882.27 | 7,184.10 | 7,670.65 | ||||||||||
Raw Materials | 423.00 | 431.05 | 362.20 | 229.35 | 580.51 | 930.46 | 936.88 | 1,119.04 | 1,496.41 | 5,602.51 | ||||||||||
| Power & Fuel Cost | 40.90 | 41.36 | 46.06 | 22.72 | 51.37 | 62.67 | 69.04 | 77.54 | 115.03 | |||||||||||
| Employee Cost | 353.47 | 422.91 | 440.55 | 230.13 | 588.78 | 759.92 | 810.04 | 937.12 | 1,179.71 | |||||||||||
| Selling & Administrative Expenses | 593.95 | 647.99 | 630.23 | 153.00 | 208.86 | 291.42 | 631.33 | 741.49 | 584.80 | |||||||||||
| Operating & Other expenses | 56.61 | 72.57 | 56.80 | 330.25 | 904.99 | 953.46 | 1,143.55 | 1,336.89 | 1,877.34 | |||||||||||
EBITDA | 199.89 | 178.59 | 212.23 | 141.66 | 284.90 | 1,060.89 | 1,379.77 | 1,670.19 | 1,930.81 | 2,068.14 | ||||||||||
| Depreciation/Amortization | 95.51 | 94.42 | 102.64 | 45.64 | 174.09 | 221.12 | 232.19 | 244.98 | 359.42 | 386.66 | ||||||||||
| PBIT | 104.38 | 84.17 | 109.59 | 96.02 | 110.81 | 839.77 | 1,147.58 | 1,425.21 | 1,571.39 | 1,681.48 | ||||||||||
| Interest & Other Items | 99.68 | 99.37 | 101.27 | 83.24 | 179.46 | 100.87 | 83.86 | 59.89 | 165.02 | 195.99 | ||||||||||
| PBT | 4.70 | -15.20 | 8.32 | 12.78 | -68.65 | 738.90 | 1,063.72 | 1,365.32 | 1,406.37 | 1,485.49 | ||||||||||
| Taxes & Other Items | -11.09 | 9.95 | 11.33 | -46.21 | 68.90 | 133.85 | -39.79 | 307.68 | 330.49 | 337.91 | ||||||||||
| Net Income | 15.79 | -25.15 | -3.01 | 58.99 | -137.55 | 605.05 | 1,103.51 | 1,057.64 | 1,075.88 | 1,147.58 | ||||||||||
| EPS | 0.29 | -0.47 | -0.06 | 1.10 | -1.83 | 6.25 | 11.37 | 10.89 | 11.07 | 11.80 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.50 | 1.50 | 1.50 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.14 | 0.14 | 0.13 |
MAXHEALTH Company Updates
FY 2026FY 2026
Investor Presentation
Aug 29PDF
MAXHEALTH Stock Peers
MAXHEALTH Past Performance & Peer Comparison
MAXHEALTH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Max Healthcare Institute Ltd | 101.70 | 11.66 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 77.39 | 10.08 | 0.16% |
| Fortis Healthcare Ltd | 98.48 | 8.31 | 0.10% |
| Narayana Hrudayalaya Ltd | 46.78 | 10.19 | 0.25% |
MAXHEALTH Stock Price Comparison
Compare MAXHEALTH with any stock or ETFCompare MAXHEALTH with any stock or ETF
MAXHEALTH
MAXHEALTH Holdings
MAXHEALTH Shareholdings
MAXHEALTH Promoter Holdings Trend
MAXHEALTH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MAXHEALTH Institutional Holdings Trend
MAXHEALTH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 2.96%
MAXHEALTH Shareholding Pattern
MAXHEALTH Shareholding Pattern
MAXHEALTH Shareholding History
MAXHEALTH Shareholding History
Foreign Institutions
Mutual Funds Invested in MAXHEALTH
Mutual Funds Invested in MAXHEALTH
No mutual funds holding trends are available
Top 5 Mutual Funds holding Max Healthcare Institute Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7131% | Percentage of the fund’s portfolio invested in the stock 0.99% | Change in the portfolio weight of the stock over the last 3 months -0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/129 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6418% | Percentage of the fund’s portfolio invested in the stock 1.79% | Change in the portfolio weight of the stock over the last 3 months -0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 51/99 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.5439% | Percentage of the fund’s portfolio invested in the stock 1.02% | Change in the portfolio weight of the stock over the last 3 months -0.43% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 61/71 (-11) |
Compare 3-month MF holding change on Screener
smallcases containing MAXHEALTH stock
smallcases containing MAXHEALTH stock
Looks like this stock is not in any smallcase yet.
MAXHEALTH Events
MAXHEALTH Events
MAXHEALTH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MAXHEALTH Dividend Trend
No dividend trend available
MAXHEALTH Upcoming Dividends
MAXHEALTH Upcoming Dividends
No upcoming dividends are available
MAXHEALTH Past Dividends
MAXHEALTH Past Dividends
Cash Dividend
Ex DateEx DateJul 4, 2025
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 4, 2025
Cash Dividend
Ex DateEx DateAug 23, 2024
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Aug 23, 2024
Cash Dividend
Ex DateEx DateSep 8, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 8, 2023
MAXHEALTH Stock News & Opinions
MAXHEALTH Stock News & Opinions
Articles & Videos
Spotlight
Max Healthcare Institute Ltd leads losers in 'A' group
Sun TV Network Ltd, Cholamandalam Financial Holdings Ltd, Adani Power Ltd and Sammaan Capital Ltd are among the other losers in the BSE's 'A' group today, 03 October 2025.Max Healthcare Institute Ltd tumbled 4.38% to Rs 1063.85 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 95187 shares were traded on the counter so far as against the average daily volumes of 79922 shares in the past one month.Sun TV Network Ltd crashed 4.26% to Rs 576.45. The stock was the second biggest loser in 'A' group.On the BSE, 1.11 lakh shares were traded on the counter so far as against the average daily volumes of 35875 shares in the past one month.Cholamandalam Financial Holdings Ltd lost 3.55% to Rs 1840.2. The stock was the third biggest loser in 'A' group.On the BSE, 12692 shares were traded on the counter so far as against the average daily volumes of 6930 shares in the past one month.Adani Power Ltd shed 2.98% to Rs 147.9. The stock was the fourth biggest loser in 'A' group.On the BSE, 88.67 lakh shares were traded on the counter so far as against the average daily volumes of 52.83 lakh shares in the past one month.Sammaan Capital Ltd corrected 2.89% to Rs 164.65. The stock was the fifth biggest loser in 'A' group.On the BSE, 41.76 lakh shares were traded on the counter so far as against the average daily volumes of 14.65 lakh shares in the past one month.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Max Healthcare Institute consolidated net profit rises 30.35% in the June 2025 quarter
Net profit of Max Healthcare Institute rose 30.35% to Rs 307.97 crore in the quarter ended June 2025 as against Rs 236.27 crore during the previous quarter ended June 2024. Sales rose 31.41% to Rs 2027.57 crore in the quarter ended June 2025 as against Rs 1542.95 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales2027.571542.95 31 OPM %25.7925.11 - PBDT504.57398.21 27 PBT400.43321.31 25 NP307.97236.27 30 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Max Healthcare Institute approves lease agreement to establish 130-bed hospital in Dehradun
The Board of Max Healthcare Institute at its meeting held on 13 August 2025 has approved to enter into an agreement to lease with Goyal Agrim Infra Realty LLP for setting up ~130 bedded hospital at Dehradun, Uttarakhand on a built-to-suit basis. Goyal Agrim will construct, develop and furnish the hospital building as per the Company's specifications and requirements at its own costs and expenses. The responsibility for construction of hospital including obtaining of approvals like occupancy certificate is with Goyal Agrim. The initial lease term will be 29 years and shall further be renewed for 29 years. Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Max Healthcare Institute allots 80,000 equity shares under ESOS
Max Healthcare Institute has allotted 80,000 equity shares under ESOS on 12 August 2025. With this allotment, the paid up equity share capital has increased to 972,22,68,430 equity shares of Rs 10 each. Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Max Healthcare Institute to conduct board meeting
Max Healthcare Institute will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Max Healthcare Institute schedules AGM
Max Healthcare Institute announced that the 24th Annual General Meeting(AGM) of the company will be held on 30 July 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Max Healthcare Institute consolidated net profit rises 26.82% in the March 2025 quarter
Net profit of Max Healthcare Institute rose 26.82% to Rs 319.00 crore in the quarter ended March 2025 as against Rs 251.54 crore during the previous quarter ended March 2024. Sales rose 34.21% to Rs 1909.74 crore in the quarter ended March 2025 as against Rs 1422.90 crore during the previous quarter ended March 2024. For the full year,net profit rose 1.72% to Rs 1075.88 crore in the year ended March 2025 as against Rs 1057.64 crore during the previous year ended March 2024. Sales rose 30.01% to Rs 7028.46 crore in the year ended March 2025 as against Rs 5406.02 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1909.741422.90 34 7028.465406.02 30 OPM %26.7926.81 -26.3027.60 - PBDT503.33406.05 24 1839.421610.30 14 PBT402.50335.73 20 1480.001365.32 8 NP319.00251.54 27 1075.881057.64 2 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Board of Max Healthcare Institute recommends final dividend
Max Healthcare Institute announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Board of Max Healthcare Institute approves expansion of bed capacity of MSSH Nagpur
The Board of Max Healthcare Institute at its meeting held on 20 May 2025 has approved the expansion of bed capacity of Max Super Speciality Hospital, Nagpur (MSSH Nagpur) by adding ~100 beds to the existing bed capacity of 186 beds by way of construction of two additional floors on the existing building. MSSH Nagpur is run and operated by Alexis Multi-Speciality Hospital, a wholly-owned subsidiary of the Company. Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Max Healthcare Institute to conduct board meeting
Max Healthcare Institute will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 45.36%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 2.66% to 9%
Over the last 5 years, net income has grown at a yearly rate of 78.73%, vs industry avg of 42.46%